[{"address1": "245 Main Street", "address2": "Second Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 500 8080", "website": "https://immuneering.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 54, "companyOfficers": [{"maxAge": 1, "name": "Dr. Benjamin J. Zeskind M.B.A., Ph.D.", "age": 42, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 941316, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert J. Carpenter M.B.A., M.S.", "age": 78, "title": "Co-Founder & Chair Emeritus", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 45000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brett M. Hall Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 918124, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael D. Bookman J.D.", "age": 37, "title": "Chief Legal Officer & Secretary", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 689959, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mallory  Morales CPA", "age": 41, "title": "Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Paula  George CPA", "title": "Director of Accounting & Operations and Assistant Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leah R. Neufeld", "age": 52, "title": "Chief People Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  King Ph.D.", "title": "Head of Discovery & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Praveen  Nair Ph.D.", "title": "Head of Translational Pharmacology & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harold E. Brakewood", "age": 58, "title": "Chief Business Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 579769, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.69, "open": 6.63, "dayLow": 6.35, "dayHigh": 6.705, "regularMarketPreviousClose": 6.69, "regularMarketOpen": 6.63, "regularMarketDayLow": 6.35, "regularMarketDayHigh": 6.705, "payoutRatio": 0.0, "beta": 0.455, "forwardPE": -3.902439, "volume": 717836, "regularMarketVolume": 717836, "averageVolume": 1940782, "averageVolume10days": 772290, "averageDailyVolume10Day": 772290, "bid": 4.87, "ask": 8.49, "bidSize": 2, "askSize": 2, "marketCap": 413247808, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 10.08, "allTimeHigh": 33.99, "allTimeLow": 1.0, "fiftyDayAverage": 6.5796, "twoHundredDayAverage": 3.9143, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 189601040, "profitMargins": 0.0, "floatShares": 45260318, "sharesOutstanding": 64569967, "sharesShort": 7679652, "sharesShortPriorMonth": 7692365, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.1189, "heldPercentInsiders": 0.17819001, "heldPercentInstitutions": 0.48393002, "shortRatio": 5.93, "shortPercentOfFloat": 0.137, "impliedSharesOutstanding": 64569967, "bookValue": 3.591, "priceToBook": 1.7822334, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -62496372, "trailingEps": -1.79, "forwardEps": -1.64, "enterpriseToEbitda": -2.971, "52WeekChange": 2.1261683, "SandP52WeekChange": 0.13287461, "quoteType": "EQUITY", "currentPrice": 6.4, "targetHighPrice": 30.0, "targetLowPrice": 11.0, "targetMeanPrice": 16.83333, "targetMedianPrice": 14.0, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 227563072, "totalCashPerShare": 3.524, "ebitda": -63817392, "totalDebt": 3916329, "quickRatio": 23.84, "currentRatio": 24.002, "debtToEquity": 1.718, "returnOnAssets": -0.25912002, "returnOnEquity": -0.4375, "freeCashflow": -27747748, "operatingCashflow": -50014512, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": 0.3124997, "postMarketPrice": 6.42, "postMarketChange": 0.01999998, "regularMarketChange": -0.29, "regularMarketDayRange": "6.35 - 6.705", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1940782, "fiftyTwoWeekLowChange": 5.3, "fiftyTwoWeekLowChangePercent": 4.818182, "fiftyTwoWeekRange": "1.1 - 10.08", "fiftyTwoWeekHighChange": -3.6799998, "fiftyTwoWeekHighChangePercent": -0.36507934, "fiftyTwoWeekChangePercent": 212.61682, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "corporateActions": [], "postMarketTime": 1764981668, "regularMarketTime": 1764968400, "marketState": "CLOSED", "shortName": "Immuneering Corporation", "earningsTimestamp": 1762981200, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "earningsCallTimestampStart": 1762808400, "earningsCallTimestampEnd": 1762808400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.79, "epsForward": -1.64, "epsCurrentYear": -1.41667, "priceEpsCurrentYear": -4.517637, "fiftyDayAverageChange": -0.17959976, "fiftyDayAverageChangePercent": -0.027296457, "twoHundredDayAverageChange": 2.4857001, "twoHundredDayAverageChangePercent": 0.63503057, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "cryptoTradeable": false, "exchange": "NGM", "messageBoardId": "finmb_308350677", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.33483, "regularMarketPrice": 6.4, "longName": "Immuneering Corporation", "displayName": "Immuneering", "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]